Literature DB >> 7904176

Haemopoietic stem/progenitor cell transplant in Fanconi anaemia using HLA-matched sibling umbilical cord blood cells.

M Kohli-Kumar1, N T Shahidi, H E Broxmeyer, M Masterson, C Delaat, J Sambrano, C Morris, A D Auerbach, R E Harris.   

Abstract

There have only been a few reports documenting the use of umbilical cord blood as a source of stem cells for haemopoietic reconstitution. We report our experience with a child with Fanconi anaemia (FA) who underwent a stem cell transplant using umbilical cord blood cells from his HLA matched sibling. Although the engraftment was somewhat slow, it was complete and comparable to other transplants performed in FA patients using HLA matched sibling marrow. There was no graft-versus-host disease. The post-transplant period was uncomplicated and, at a follow-up of 36 months, this child is well with normal blood counts and immune function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904176     DOI: 10.1111/j.1365-2141.1993.tb03192.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.

Authors:  M Pulsipher; G M Kupfer; D Naf; A Suliman; J S Lee; P Jakobs; M Grompe; H Joenje; C Sieff; E Guinan; R Mulligan; A D D'Andrea
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

2.  Cord blood banking.

Authors: 
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

Review 3.  Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.

Authors:  Hal E Broxmeyer
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

Review 4.  Umbilical cord blood transplantation: the first 25 years and beyond.

Authors:  Karen K Ballen; Eliane Gluckman; Hal E Broxmeyer
Journal:  Blood       Date:  2013-05-14       Impact factor: 22.113

5.  Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells.

Authors:  G Risdon; J Gaddy; M Horie; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

6.  High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.

Authors:  Hal E Broxmeyer; Edward F Srour; Giao Hangoc; Scott Cooper; Stacie A Anderson; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

Review 7.  Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns.

Authors:  Hal E Broxmeyer; Sherif Farag
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

Review 8.  Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation.

Authors:  Hal E Broxmeyer
Journal:  Transfus Apher Sci       Date:  2016-05-12       Impact factor: 1.764

9.  Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions.

Authors:  A De León; H Mayani; O T Ramírez
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

10.  Autologous cord blood harvesting in North Eastern Italy: ethical questions and emerging hopes for curing diabetes and celiac disease.

Authors:  Sergio Parco; Fulvia Vascotto
Journal:  Int J Gen Med       Date:  2012-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.